Monoclonal antibody-based targeted therapy in breast cancer: current status and future directions . Drugs 2006 ; 66 : 1577 - 1591 .Bernard-Marty C, Lebrun F, Awada A, Piccart MJ. Monoclonal antibody-based targeted therapy in breast cancer: current status and future directions. Drugs 2006;66...
Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancerJiaqing Hao, Rong Jin, Yanmei Yi, Xingshan Jiang, Jianyu Yu, Zhen Xu, Nicholas J. Schnicker, Michael S. Chimenti, Sonia L. Sugg & Bing Li ...
Treatment of cancer has dramatically changed in recent years. Some of this change is because of the introduction of monoclonal antibodies into clinical practice. The exact mechanism of action of the clinically relevant antibodies remains unknown. This ch
aVEGFA-specific humanized monoclonal antibody, blocks binding of VEGF to its receptor and is approved for the treatment of breast, colorectal and non-small-cell lung cancer in combination with cytotoxic chemotherapy.
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? Br J Cancer 2006;94:259–67. CAS PubMed Google Scholar Asano M, Yukita A, Matsumoto T, et al. An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor ...
Monoclonal antibodies in breast cancer: A critical appraisal Critical Reviews in Oncology/HematologyJournal2023,Critical Reviews in Oncology/Hematology AkankshaBehl, ...Anil K.Chhillar 10Conclusion and future perspectives Monoclonal antibodydrugs are cancer treatment therapies that include naturalimmune system...
Monoclonal Antibody Therapy In subject area: Neuroscience Monoclonal Antibody Therapy is a cancer treatment that utilizes antibodies to target tumor cells and stimulate the immune system for long-lasting responses. AI generated definition based on: Methods in Cell Biology, 2023 About this pageSet alert...
Mechanistic studies showed that treatment with this antibody increased anti-tumour cellular immunity functioning on the cells presenting tumour antigens. Article CAS PubMed Google Scholar Luft, T. et al. IL-1 β enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a ...
A chemotherapy regimen for the treatment of colorectal cancer, made up of the drug folinic acid (Leucovorin), fluorouracil (5-FU) and irinotecan (Camptosar). Heregulin A family of ligands known to bind the HER3 and HER4 receptors, also capable of inducing phosphorylation of HER2. ...
Treatment of patients with HER2-expressing breast cancer with a humanized anti-HER2 monoclonal antibody trastuzumab has resulted in improved survival. Several ... Tolmachev - 《Current Pharmaceutical Design》 被引量: 130发表: 2008年 Anti-HER2 antibody enhances the growth inhibitory effect of anti-oes...